GIESEKE; Friederike
Patent Applications and Registrations
Patent applications and USPTO patent grants for GIESEKE; Friederike.The latest application filed is for "therapeutic rna and anti-pd1 antibodies for advanced stage solid tumor cancers".
- GIESEKE; Friederike - Mainz DE
| Patent | Date |
|---|---|
| Therapeutic RNA and Anti-PD1 Antibodies for Advanced Stage Solid Tumor Cancers App 20220288199 - MASCIARI; Serena ; et al. | 2022-09-15 |
| Multispecific antibodies against CD40 and CD137 Grant 11,440,966 - Altintas , et al. September 13, 2 | 2022-09-13 |
| Multispecific Antibodies Against Cd40 And Cd137 App 20220064317 - ALTINTAS; Isil ; et al. | 2022-03-03 |
| Therapeutic RNA for Advanced Stage Solid Tumor Cancers App 20220040218 - Masciari; Serena ; et al. | 2022-02-10 |
| Multispecific Antibodies Against Cd40 And Cd137 App 20220033510 - ALTINTAS; Isil ; et al. | 2022-02-03 |
| Antibody Formulation App 20210369842 - ALTINTAS; Isil ; et al. | 2021-12-02 |
| Multispecific Antibodies Against Cd40 And Cd137 App 20210317225 - ALTINTAS; Isil ; et al. | 2021-10-14 |
| IL2 Agonists App 20210292386 - Sahin; Ugur ; et al. | 2021-09-23 |
| Therapeutic RNA App 20210290730 - Gieseke; Friederike ; et al. | 2021-09-23 |
| Binding Agents Binding To Pd-l1 And Cd137 And Use Thereof App 20210277133 - ALTINTAS; Isil ; et al. | 2021-09-09 |
| Binding Agents Binding To Pd-l1 And Cd137 And Use Thereof App 20210269541 - ALTINTAS; Isil ; et al. | 2021-09-02 |
| Agonistic Tnf Receptor Binding Agents App 20210253725 - Sahin; Ugur ; et al. | 2021-08-19 |
| Methods of producing multispecific antibodies against CD40 and CD137 Grant 11,091,557 - Altintas , et al. August 17, 2 | 2021-08-17 |
| Multispecific antibodies against CD40 and CD137 Grant 11,084,882 - Altintas , et al. August 10, 2 | 2021-08-10 |
| Binding Agents Binding To Pd-l1 And Cd137 And Use Thereof App 20210163616 - ALTINTAS; Isil ; et al. | 2021-06-03 |
| Binding agents binding to PD-L1 and CD137 and use thereof Grant 10,968,280 - Altintas , et al. April 6, 2 | 2021-04-06 |
| Agonistic tumor necrosis factor (TNF) receptor binding agents Grant 10,927,181 - Sahin , et al. February 23, 2 | 2021-02-23 |
| Nucleic acid molecules encoding cytokine fusion proteins comprising tumor necrosis factor (TNF) superfamily ligands Grant 10,808,019 - Sahin , et al. October 20, 2 | 2020-10-20 |
| Multispecific Antibodies Against Cd40 And Cd137 App 20200247899 - Kind Code | 2020-08-06 |
| RNA molecules encoding cytokine fusion proteins and methods of use thereof Grant 10,669,322 - Sahin , et al. | 2020-06-02 |
| Binding Agents Binding To Pd-l1 And Cd137 And Use Thereof App 20200165349 - ALTINTAS; Isil ; et al. | 2020-05-28 |
| Therapeutic RNA App 20200147176 - Gieseke; Friederike ; et al. | 2020-05-14 |
| Agonistic Tnf Receptor Binding Agents App 20200079866 - Sahin; Ugur ; et al. | 2020-03-12 |
| Multispecific Antibodies Against Cd40 And Cd137 App 20200062853 - ALTINTAS; Isil ; et al. | 2020-02-27 |
| Methods of inducing T cell activation by administering an antibody comprising CD40 and 4-1BB (CD137) binding domains Grant 10,457,735 - Sahin , et al. October 29, 2 | 2019-10-29 |
| Cytokine Fusion Proteins App 20190276511 - Sahin; Ugur ; et al. | 2019-09-12 |
| Cytokine fusion proteins Grant 10,301,368 - Sahin , et al. | 2019-05-28 |
| Novel Cytokine Fusion Proteins App 20180371042 - SAHIN; Ugur ; et al. | 2018-12-27 |
| Agonistic Tnf Receptor Binding Agents App 20180194849 - Sahin; Ugur ; et al. | 2018-07-12 |
| Cytokine Fusion Proteins App 20180002392 - Sahin; Ugur ; et al. | 2018-01-04 |
uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.
While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.
All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.
| 